Nationwide Children's Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 233 studies whose lead sponsor is Nationwide Children's Hospital. 43 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Nationwide Children's Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions Nationwide Children's Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 233. Browse all 233 →
- Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial DiseaseRecruitingNCT03622359Not applicable
- ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade GliomasRecruitingNCT06838676Phase 2
- Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk MedulloblastomaNot yet recruitingNCT07291102Phase 3
- Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)Not yet recruitingNCT07206849Phase 2
- VR for Steroid Joint Injections - FeasibilityEnrolling by invitationNCT07778069Not applicable
- VR-PAT and fNIRS to Identify CNS Biomarkers of PainNot yet recruitingNCT06303687Not applicable
- TetraGraph to Evaluate Onset and Recovery Times of RocuroniumEnrolling by invitationNCT07435792Not applicable
- Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNot yet recruitingNCT07644312Phase 2
- Targeted Pediatric High-Grade Glioma TherapyRecruitingNCT05839379
- Transauricular Neurostimulation for Abdominal Pain Due to DGBIRecruitingNCT07798180Not applicable
- Parent Implemented Oral Nutrition, Eating, and Esophageal Reflexes Reintegration Protocol: RCTNot yet recruitingNCT07035912Not applicable
- VR-PAT for Pain and Anxiety Management During Pediatric Dermatologic Laser ProceduresEnrolling by invitationNCT05645224Not applicable
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent MedulloblastomaRecruitingNCT05096481Phase 2
- Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular DystrophyRecruitingNCT06503367
- Little NIRVANA for Pediatric Pain and AnxietyEnrolling by invitationNCT06795126Not applicable
- VR-PAT During Home Burn Dressings - MultisiteEnrolling by invitationNCT05673551Not applicable
- The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant PatientsRecruitingNCT07718204Not applicable
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsRecruitingNCT05278208Phase 1/2
- Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionRecruitingNCT06333899Early Phase 1
- GERD Infant Feeding Therapeutics Trial (GIFT Trial)RecruitingNCT06114836Not applicable
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantRecruitingNCT05843253Phase 2
- ACTEMRA® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaRecruitingNCT05233397Phase 2
- Pediatric Cochlear Implant Remote Programming and AssessmentRecruitingNCT07035873Not applicable
- MEKTOVI® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaRecruitingNCT05286788Phase 2
- Genetics of Congenital Heart DiseaseRecruitingNCT01192048
- DOSC and Association With Neighborhood Opportunity: Phase IIRecruitingNCT05939570
- Improving Status Epilepticus Treatment TimesRecruitingNCT06194747Not applicable
- A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK FusionRecruitingNCT04655404Early Phase 1
- Healthy Children and Virtual Reality Mediation of Simulated PainEnrolling by invitationNCT06854991Not applicable
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODSRecruitingNCT05267821Phase 2/3
- A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft TissueRecruitingNCT05634369Phase 1/2
- Preparing for Life and Academics for Young Childhood Cancer SurvivorsRecruitingNCT06769334Not applicable
- Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AMLNot yet recruitingNCT07026942Phase 1/2
- Peripheral Regional Blockade and EMGEnrolling by invitationNCT06982027Not applicable
- Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHLNot yet recruitingNCT05779930Early Phase 1
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsRecruitingNCT05135975Phase 2
- Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular GraftsRecruitingNCT04467671Phase 2
- Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus InfectionsRecruitingNCT04722029Phase 1/2
- Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer CellsRecruitingNCT04254419Phase 1
- αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)RecruitingNCT06082947Not applicable
- Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsRecruitingNCT05547165Not applicable
- Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AMLRecruitingNCT05503134Phase 1/2
- Oral Device Clinical TrialEnrolling by invitationNCT05022368Phase 1
- NK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabActive, not recruitingNCT04211675Phase 1/2
- Applying Directly Observed Therapy to Hydroxyurea to Realize EffectivenessCompletedNCT06264700Not applicable
- Regional Anesthesia EMG StudyCompletedNCT06287151Not applicable
- Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1AWithdrawnNCT03520751Phase 1/2
- Early Predictors of Necrotizing Enterocolitis in NeonatesActive, not recruitingNCT03210831
- Evaluating an Intervention to Prevent Overdoses in Rural and Urban CountiesActive, not recruitingNCT05463341Not applicable
- GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS StudyCompletedNCT03769844Phase 4